Michael J. Garabedian - Publications

Affiliations: 
New York University, New York, NY, United States 
Area:
Molecular Biology, Microbiology Biology
Website:
https://med.nyu.edu/microbiology-parasitology/faculty/garabedian-lab-microbiology

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ruoff R, Weber H, Wang Y, Huang H, Shapiro E, Fenyö D, Garabedian MJ. MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs. Scientific Reports. 13: 18227. PMID 37880276 DOI: 10.1038/s41598-023-45199-9  0.308
2023 Habault J, Schneider JA, Ha S, Ruoff R, Doro Pereira LD, Puccini J, Ranieri M, Ayasun R, Deng J, Kasper AC, Bar-Sagi D, Wong KK, Zoubeidi A, Claessens F, Wise DR, ... ... Garabedian MJ, et al. A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer. Molecular Cancer Therapeutics. PMID 37486978 DOI: 10.1158/1535-7163.MCT-23-0196  0.351
2021 Ruff SE, Vasilyev N, Nudler E, Logan SK, Garabedian MJ. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer. Communications Biology. 4: 1221. PMID 34697370 DOI: 10.1038/s42003-021-02723-9  0.42
2021 Weber H, Ruoff R, Garabedian MJ. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen. Plos Genetics. 17: e1008540. PMID 33513133 DOI: 10.1371/journal.pgen.1008540  0.368
2020 Ruff SE, Logan SK, Garabedian MJ, Huang TT. Roles for MDC1 in cancer development and treatment. Dna Repair. 95: 102948. PMID 32866776 DOI: 10.1016/J.Dnarep.2020.102948  0.335
2020 Voisin M, Gage M, Becares N, Shrestha E, Fisher EA, Pineda-Torra I, Garabedian MJ. LXRα phosphorylation in cardiometabolic disease: insight from mouse models. Endocrinology. PMID 32496563 DOI: 10.1210/Endocr/Bqaa089  0.358
2019 Wang Y, Schafler ED, Thomas PA, Ha S, David G, Adney E, Garabedian MJ, Lee P, Logan SK. Prostate-specific loss of UXT promotes cancer progression. Oncotarget. 10: 707-716. PMID 30774773 DOI: 10.18632/Oncotarget.26573  0.376
2019 Becares N, Gage MC, Voisin M, Shrestha E, Martin-Gutierrez L, Liang N, Louie R, Pourcet B, Pello OM, Luong TV, Goñi S, Pichardo-Almarza C, Røberg-Larsen H, Diaz-Zuccarini V, Steffensen KR, ... ... Garabedian MJ, et al. Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. Cell Reports. 26: 984-995.e6. PMID 30673619 DOI: 10.1016/J.Celrep.2018.12.094  0.323
2018 Schneider JA, Craven TW, Kasper AC, Yun C, Haugbro M, Briggs EM, Svetlov V, Nudler E, Knaut H, Bonneau R, Garabedian MJ, Kirshenbaum K, Logan SK. Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Nature Communications. 9: 4396. PMID 30352998 DOI: 10.1038/S41467-018-06845-3  0.339
2018 Mukudai S, Hiwatashi N, Bing R, Garabedian M, Branski RC. Phosphorylation of the glucocorticoid receptor alters SMAD signaling in vocal fold fibroblasts. The Laryngoscope. PMID 30325506 DOI: 10.1002/Lary.27570  0.401
2017 Weber H, Garabedian MJ. The Mediator Complex in Genomic and Non-Genomic Signaling in Cancer. Steroids. PMID 29157917 DOI: 10.1016/J.Steroids.2017.11.007  0.477
2017 Garabedian MJ, Harris CA, Jeanneteau F. Glucocorticoid receptor action in metabolic and neuronal function. F1000research. 6: 1208. PMID 28781762 DOI: 10.12688/F1000Research.11375.1  0.429
2016 Mita P, Savas JN, Briggs EM, Ha S, Gnanakkan V, Yates JR, Robins DM, David G, Boeke JD, Garabedian MJ, Logan SK. URI Regulates KAP1 Phosphorylation and Transcriptional Repression Via PP2A Phosphatase in Prostate Cancer Cells. The Journal of Biological Chemistry. PMID 27780869 DOI: 10.1074/Jbc.M116.741660  0.428
2016 Basu-Roy U, Han E, Rattanakorn K, Gadi A, Verma N, Maurizi G, Gunaratne PH, Coarfa C, Kennedy OD, Garabedian MJ, Basilico C, Mansukhani A. PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. Oncotarget. PMID 27528232 DOI: 10.18632/Oncotarget.11273  0.41
2016 Wang Y, Dehigaspitiya DC, Levine PM, Profit AA, Haugbro M, Imberg-Kazdan K, Logan SK, Kirshenbaum K, Garabedian MJ. Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation. Cancer Research. PMID 27488525 DOI: 10.1158/0008-5472.Can-16-0385  0.414
2016 Savic D, Ramaker RC, Roberts BS, Dean EC, Burwell TC, Meadows SK, Cooper SJ, Garabedian MJ, Gertz J, Myers RM. Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Medicine. 8: 74. PMID 27401066 DOI: 10.1186/S13073-016-0328-6  0.46
2016 Wang Y, Ledet RJ, Imberg-Kazdan K, Logan SK, Garabedian MJ. Dynein axonemal heavy chain 8 promotes androgen receptor activity and associates with prostate cancer progression. Oncotarget. PMID 27363033 DOI: 10.18632/Oncotarget.10284  0.432
2016 Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR, Moore KJ, Fisher EA, Garabedian MJ. PARP-1 Represses LXR-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages. The Journal of Biological Chemistry. PMID 27026705 DOI: 10.1074/Jbc.M116.726729  0.431
2016 Ouimet M, Hennessy EJ, van Solingen C, Koelwyn GJ, Hussein MA, Ramkhelawon B, Rayner KJ, Temel RE, Perisic L, Hedin U, Maegdefessel L, Garabedian MJ, Holdt LM, Teupser D, Moore KJ. miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26941018 DOI: 10.1161/Atvbaha.116.307282  0.322
2016 Wang Y, Levine P, Dehigaspitiya D, Profit A, Logan S, Imberg-Kazdan K, Kirshenbaum K, Garabedian M. Abstract 4852: Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation Cancer Research. 76: 4852-4852. DOI: 10.1158/1538-7445.Am2016-4852  0.372
2016 Ledet R, Logan S, Garabedian M. MP84-12 COMBATTING AR N-TERMINAL VARIANT-DRIVEN ENZALUTAMIDE RESISTANT PROSTATE CANCER BY TARGETING THE KINASE HIPK2 Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2236  0.329
2015 Arango-Lievano M, Lambert WM, Bath KG, Garabedian MJ, Chao MV, Jeanneteau F. Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment. Proceedings of the National Academy of Sciences of the United States of America. PMID 26630005 DOI: 10.1073/Pnas.1509045112  0.345
2015 Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Evensen NA, Bride K, Waanders AJ, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar S, Park E, ... ... Garabedian MJ, et al. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood. PMID 26324703 DOI: 10.1182/Blood-2015-04-639138  0.347
2015 Hussein MA, Shrestha E, Ouimet M, Barrett TJ, Leone S, Moore KJ, Hérault Y, Fisher EA, Garabedian MJ. LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. Plos One. 10: e0135218. PMID 26288135 DOI: 10.1371/Journal.Pone.0135218  0.314
2015 Wu C, Hussein MA, Shrestha E, Leone S, Aiyegbo MS, Lambert WM, Pourcet B, Cardozo T, Gustafson JA, Fisher EA, Pineda-Torra I, Garabedian MJ. Modulation of Macrophage Gene Expression via Liver X Receptor α Serine 198 Phosphorylation. Molecular and Cellular Biology. 35: 2024-34. PMID 25825525 DOI: 10.1128/Mcb.00985-14  0.47
2014 Levine PM, Garabedian MJ, Kirshenbaum K. Targeting the androgen receptor with steroid conjugates. Journal of Medicinal Chemistry. 57: 8224-37. PMID 24936953 DOI: 10.1021/Jm500101H  0.394
2014 Jones CL, Bhatla T, Blum R, Wang J, Paugh SW, Wen X, Bourgeois W, Bitterman DS, Raetz EA, Morrison DJ, Teachey DT, Evans WE, Garabedian MJ, Carroll WL. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. The Journal of Biological Chemistry. 289: 20502-15. PMID 24895125 DOI: 10.1074/Jbc.M114.569889  0.401
2014 Peffer ME, Chandran UR, Luthra S, Volonte D, Galbiati F, Garabedian MJ, Monaghan AP, DeFranco DB. Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells. Molecular and Cellular Biology. 34: 2611-23. PMID 24777604 DOI: 10.1128/Mcb.01121-13  0.474
2014 Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar SC, Raetz EA, Hermiston ML, Garabedian MJ, Porter CC, et al. MAPK Signaling Cascades Mediate Distinct Glucocorticoid Resistance Mechanisms in Pediatric B-Precursor ALL Blood. 124: 789-789. DOI: 10.1182/Blood.V124.21.789.789  0.388
2013 Lee E, Madar A, David G, Garabedian MJ, Dasgupta R, Logan SK. Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 15710-5. PMID 24019458 DOI: 10.1073/Pnas.1218168110  0.428
2013 Lambert WM, Xu CF, Neubert TA, Chao MV, Garabedian MJ, Jeanneteau FD. Brain-derived neurotrophic factor signaling rewrites the glucocorticoid transcriptome via glucocorticoid receptor phosphorylation. Molecular and Cellular Biology. 33: 3700-14. PMID 23878391 DOI: 10.1128/Mcb.00150-13  0.414
2013 Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, Reuter V, Gerald W, Giri DD, Melamed J, Garabedian MJ, Lee P, Logan SK. Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 119: 2532-40. PMID 23605249 DOI: 10.1002/Cncr.28092  0.355
2013 Imberg-Kazdan K, Ha S, Greenfield A, Poultney CS, Bonneau R, Logan SK, Garabedian MJ. A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells. Genome Research. 23: 581-91. PMID 23403032 DOI: 10.1101/Gr.144774.112  0.455
2013 Ha S, Iqbal NJ, Mita P, Ruoff R, Gerald WL, Lepor H, Taneja SS, Lee P, Melamed J, Garabedian MJ, Logan SK. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Oncogene. 32: 3992-4000. PMID 22986532 DOI: 10.1038/Onc.2012.412  0.442
2013 Kirshenbaum K, Levine P, Lee E, Imberg-Kazdan K, Logan S, Garabedian M. 981 TARGETING ANDROGEN RECEPTOR-DEPENDENT PROSTATE CANCER WITH MULTIVALENT ETHISTERONE CONJUGATES Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.563  0.432
2013 Lee E, Garabedian M, DasGupta R, Logan S. 796 INHIBITION OF ANDROGEN RECEPTOR AND BETA-CATENIN ACTIVITY IN PROSTATE CANCER Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.360  0.372
2012 Gertz J, Reddy TE, Varley KE, Garabedian MJ, Myers RM. Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Research. 22: 2153-62. PMID 23019147 DOI: 10.1101/Gr.135681.111  0.476
2012 Levine PM, Lee E, Greenfield A, Bonneau R, Logan SK, Garabedian MJ, Kirshenbaum K. Androgen receptor antagonism by divalent ethisterone conjugates in castrate-resistant prostate cancer cells. Acs Chemical Biology. 7: 1693-701. PMID 22871957 DOI: 10.1021/Cb300332W  0.462
2012 Ligr M, Li Y, Logan SK, Taneja S, Melamed J, Lepor H, Garabedian MJ, Lee P. Mifepristone inhibits GRβ coupled prostate cancer cell proliferation. The Journal of Urology. 188: 981-8. PMID 22819113 DOI: 10.1016/J.Juro.2012.04.102  0.432
2012 Reddy TE, Gertz J, Crawford GE, Garabedian MJ, Myers RM. The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes. Molecular and Cellular Biology. 32: 3756-67. PMID 22801371 DOI: 10.1128/Mcb.00062-12  0.455
2012 Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. Plos One. 7: e39790. PMID 22761902 DOI: 10.1371/Journal.Pone.0039790  0.706
2012 Levine PM, Imberg K, Garabedian MJ, Kirshenbaum K. Multivalent peptidomimetic conjugates: a versatile platform for modulating androgen receptor activity. Journal of the American Chemical Society. 134: 6912-5. PMID 22509763 DOI: 10.1021/Ja300170N  0.789
2012 Blind RD, Pineda-Torra I, Xu Y, Xu HE, Garabedian MJ. Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy. Biochemical and Biophysical Research Communications. 420: 839-44. PMID 22465009 DOI: 10.1016/J.Bbrc.2012.03.084  0.79
2012 Jeanneteau FD, Lambert WM, Ismaili N, Bath KG, Lee FS, Garabedian MJ, Chao MV. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proceedings of the National Academy of Sciences of the United States of America. 109: 1305-10. PMID 22232675 DOI: 10.1073/Pnas.1114122109  0.416
2012 Simpson NE, Gertz J, Imberg K, Myers RM, Garabedian MJ. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 26: 194-202. PMID 22074947 DOI: 10.1210/Me.2011-1068  0.776
2012 Obiri DD, Flink N, Maier JV, Neeb A, Maddalo D, Thiele W, Menon A, Stassen M, Kulkarni RA, Garabedian MJ, Barrios AM, Cato ACB. PEST-domain-enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice Allergy: European Journal of Allergy and Clinical Immunology. 67: 175-182. PMID 21981059 DOI: 10.1111/J.1398-9995.2011.02731.X  0.3
2011 Feig JE, Shang Y, Rotllan N, Vengrenyuk Y, Wu C, Shamir R, Torra IP, Fernandez-Hernando C, Fisher EA, Garabedian MJ. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. Plos One. 6: e28534. PMID 22163030 DOI: 10.1371/Journal.Pone.0028534  0.716
2011 Echtenkamp FJ, Zelin E, Oxelmark E, Woo JI, Andrews BJ, Garabedian M, Freeman BC. Global functional map of the p23 molecular chaperone reveals an extensive cellular network. Molecular Cell. 43: 229-41. PMID 21777812 DOI: 10.1016/J.Molcel.2011.05.029  0.308
2011 Pourcet B, Feig JE, Vengrenyuk Y, Hobbs AJ, Kepka-Lenhart D, Garabedian MJ, Morris SM, Fisher EA, Pineda-Torra I. LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circulation Research. 109: 492-501. PMID 21757649 DOI: 10.1161/Circresaha.111.241810  0.74
2011 Mita P, Savas JN, Djouder N, Yates JR, Ha S, Ruoff R, Schafler ED, Nwachukwu JC, Tanese N, Cowan NJ, Zavadil J, Garabedian MJ, Logan SK. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP. Molecular and Cellular Biology. 31: 3639-52. PMID 21730289 DOI: 10.1128/Mcb.05429-11  0.767
2011 Anacker C, Zunszain PA, Cattaneo A, Carvalho LA, Garabedian MJ, Thuret S, Price J, Pariante CM. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular Psychiatry. 16: 738-50. PMID 21483429 DOI: 10.1038/Mp.2011.26  0.305
2011 Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 7166-71. PMID 21482781 DOI: 10.1073/Pnas.1016086108  0.674
2011 Holub JM, Garabedian MJ, Kirshenbaum K. Modulation of human estrogen receptor α activity by multivalent estradiol-peptidomimetic conjugates. Molecular Biosystems. 7: 337-45. PMID 21218226 DOI: 10.1039/C0Mb00189A  0.402
2010 Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C, Liu J, Wu C, van Rooijen N, Bhardwaj N, Garabedian M, Tontonoz P, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. The Journal of Clinical Investigation. 120: 4415-24. PMID 21041949 DOI: 10.1172/Jci38911  0.701
2010 Simpson NE, Lambert WM, Watkins R, Giashuddin S, Huang SJ, Oxelmark E, Arju R, Hochman T, Goldberg JD, Schneider RJ, Reiz LF, Soares FA, Logan SK, Garabedian MJ. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Cancer Research. 70: 8446-56. PMID 20847343 DOI: 10.1158/0008-5472.Can-10-1590  0.637
2010 Ligr M, Li Y, Zou X, Daniels G, Melamed J, Peng Y, Wang W, Wang J, Ostrer H, Pagano M, Wang Z, Garabedian MJ, Lee P. Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. The American Journal of Pathology. 176: 1891-900. PMID 20167864 DOI: 10.2353/Ajpath.2010.090293  0.41
2010 Garabedian MJ, Logan SK. Glucocorticoid receptor DNA binding decoy is a gas. Science Signaling. 3: pe5. PMID 20145207 DOI: 10.1126/Scisignal.3108Pe5  0.434
2010 Peng Y, Li Y, Gellert LL, Zou X, Wang J, Singh B, Xu R, Chiriboga L, Daniels G, Pan R, Zhang DY, Garabedian MJ, Schneider RJ, Wang Z, Lee P. Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion. Journal of Cellular and Molecular Medicine. 14: 2780-9. PMID 19840198 DOI: 10.1111/J.1582-4934.2009.00936.X  0.432
2010 Logan S, Mita P, Schafler E, Garabedian M. 1294 A TRANSCRIPTION REPRESSOR COMPLEX CRITICAL FOR ANTI-ANDROGEN ACTION Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.878  0.341
2010 Garabedian M, Imberg K, Ha S, Logan S. 549 GENOME WIDE ANALYSIS OF FACTORS AFFECTING ANDROGEN RECEPTOR FUNCTION REVEALS NEW THERAPEUTIC TARGETS IN PROSTATE CANCER Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.769  0.77
2009 Reddy TE, Pauli F, Sprouse RO, Neff NF, Newberry KM, Garabedian MJ, Myers RM. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Research. 19: 2163-71. PMID 19801529 DOI: 10.1101/Gr.097022.109  0.461
2009 Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Research. 69: 3332-8. PMID 19351848 DOI: 10.1158/0008-5472.Can-08-3380  0.41
2009 Nwachukwu JC, Mita P, Ruoff R, Ha S, Wang Q, Huang SJ, Taneja SS, Brown M, Gerald WL, Garabedian MJ, Logan SK. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Research. 69: 3140-7. PMID 19318562 DOI: 10.1158/0008-5472.CAN-08-3738  0.724
2009 Torra IP, Staverosky JA, Ha S, Logan SK, Garabedian MJ. Development of phosphorylation site-specific antibodies to nuclear receptors. Methods in Molecular Biology (Clifton, N.J.). 505: 221-35. PMID 19117148 DOI: 10.1007/978-1-60327-575-0_13  0.41
2008 Garabedian MJ, Logan SK. Atypical regulation of SRC-3. Trends in Biochemical Sciences. 33: 301-4. PMID 18502645 DOI: 10.1016/J.Tibs.2008.04.011  0.443
2008 Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, Rogatsky I, Logan SK, Garabedian MJ. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Molecular Endocrinology (Baltimore, Md.). 22: 1754-66. PMID 18483179 DOI: 10.1210/Me.2007-0219  0.809
2008 Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, Kong X, McLeod M, Li Y, Li CX, Feng A, Garabedian MJ, Wang Z, Roeder RG, Lee P. Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 105: 5236-41. PMID 18356297 DOI: 10.1073/Pnas.0712262105  0.454
2008 Jeanneteau F, Garabedian MJ, Chao MV. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proceedings of the National Academy of Sciences of the United States of America. 105: 4862-7. PMID 18347336 DOI: 10.1073/Pnas.0709102105  0.406
2008 Blind RD, Garabedian MJ. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. The Journal of Steroid Biochemistry and Molecular Biology. 109: 150-7. PMID 18304804 DOI: 10.1016/J.Jsbmb.2008.01.002  0.793
2008 Li Y, Li CX, Ye H, Chen F, Melamed J, Peng Y, Liu J, Wang Z, Tsou HC, Wei J, Walden P, Garabedian MJ, Lee P. Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. Journal of Cellular and Molecular Medicine. 12: 2790-8. PMID 18266956 DOI: 10.1111/J.1582-4934.2008.00279.X  0.399
2008 Torra IP, Ismaili N, Feig JE, Xu CF, Cavasotto C, Pancratov R, Rogatsky I, Neubert TA, Fisher EA, Garabedian MJ. Phosphorylation of liver X receptor alpha selectively regulates target gene expression in macrophages. Molecular and Cellular Biology. 28: 2626-36. PMID 18250151 DOI: 10.1128/Mcb.01575-07  0.751
2008 Peng Y, Li CX, Chen F, Wang Z, Ligr M, Melamed J, Wei J, Gerald W, Pagano M, Garabedian MJ, Lee P. Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. The American Journal of Pathology. 172: 225-35. PMID 18156210 DOI: 10.2353/Ajpath.2008.070065  0.405
2008 Logan SK, Nwachukwu JC, Mita P, Taneja SS, Garabedian MJ. REGULATION OF PROSTATE CELL GROWTH THROUGH ANDROGEN RECEPTOR COFACTORS Journal of Urology. 179: 190-190. DOI: 10.1016/S0022-5347(08)60552-2  0.701
2008 Li Y, Li CX, Melamed J, Walden P, Peng Y, Lepor H, Garabedian MJ, Lee P. STROMAL AR INHIBITION OF PROSTATE CANCER GROWTH AND INVASION BY STROMAL AR AND ASSOCIATION WITH ANDROGEN INDEPENDENT DISEASE Journal of Urology. 179: 187-187. DOI: 10.1016/S0022-5347(08)60543-1  0.329
2007 Nwachukwu JC, Li W, Pineda-Torra I, Huang HY, Ruoff R, Shapiro E, Taneja SS, Logan SK, Garabedian MJ. Transcriptional regulation of the androgen receptor cofactor androgen receptor trapped clone-27. Molecular Endocrinology (Baltimore, Md.). 21: 2864-76. PMID 17761951 DOI: 10.1210/Me.2007-0094  0.762
2007 Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Molecular Endocrinology (Baltimore, Md.). 21: 1552-68. PMID 17440046 DOI: 10.1210/Me.2006-0345  0.471
2007 Liang JJ, Wang Z, Chiriboga L, Greco MA, Shapiro E, Huang H, Yang XJ, Huang J, Peng Y, Melamed J, Garabedian MJ, Lee P. The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors. The Journal of Urology. 177: 1918-22. PMID 17437848 DOI: 10.1016/J.Juro.2007.01.017  0.392
2007 Wang Z, Chen W, Kono E, Dang T, Garabedian MJ. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. Molecular Endocrinology (Baltimore, Md.). 21: 625-34. PMID 17185395 DOI: 10.1210/Me.2005-0338  0.552
2007 Holub JM, Garabedian MJ, Kirshenbaum K. Peptoids on steroids: Precise multivalent estradiol-peptidomimetic conjugates generated via azide-alkyne [3 + 2] cycloaddition reactions Qsar and Combinatorial Science. 26: 1175-1180. DOI: 10.1002/Qsar.200740074  0.322
2006 Oxelmark E, Roth JM, Brooks PC, Braunstein SE, Schneider RJ, Garabedian MJ. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. Molecular and Cellular Biology. 26: 5205-13. PMID 16809759 DOI: 10.1128/Mcb.00009-06  0.464
2006 Koklanaris N, Nwachukwu JC, Huang SJ, Guller S, Karpisheva K, Garabedian M, Lee MJ. First-trimester trophoblast cell model gene response to hypoxia. American Journal of Obstetrics and Gynecology. 194: 687-93. PMID 16522398 DOI: 10.1016/J.Ajog.2006.01.067  0.65
2006 Chen W, Rogatsky I, Garabedian MJ. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Molecular Endocrinology (Baltimore, Md.). 20: 560-72. PMID 16239257 DOI: 10.1210/Me.2005-0318  0.581
2005 Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, Shapiro E, Garabedian MJ, Logan SK. Cell-specific regulation of androgen receptor phosphorylation in vivo. The Journal of Biological Chemistry. 280: 40916-24. PMID 16210317 DOI: 10.1074/Jbc.M508442200  0.434
2005 Lee MJ, Wang Z, Yee H, Ma Y, Swenson N, Yang L, Kadner SS, Baergen RN, Logan SK, Garabedian MJ, Guller S. Expression and regulation of glucocorticoid receptor in human placental villous fibroblasts. Endocrinology. 146: 4619-26. PMID 16055431 DOI: 10.1210/En.2005-0235  0.443
2005 Li W, Cavasotto CN, Cardozo T, Ha S, Dang T, Taneja SS, Logan SK, Garabedian MJ. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. Molecular Endocrinology (Baltimore, Md.). 19: 2273-82. PMID 15919721 DOI: 10.1210/Me.2005-0134  0.435
2005 Ismaili N, Blind R, Garabedian MJ. Stabilization of the unliganded glucocorticoid receptor by TSG101. The Journal of Biological Chemistry. 280: 11120-6. PMID 15657031 DOI: 10.1074/Jbc.M500059200  0.789
2005 Koklanaris (F) N, Nwachukwu J, Huang SJ, Guller S, Garabedian M, Lee M. Placental gene response to early hypoxia American Journal of Obstetrics and Gynecology. 193: S25. DOI: 10.1016/J.Ajog.2005.10.067  0.647
2004 Szatmáry Z, Garabedian MJ, Vilcek J. Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. The Journal of Biological Chemistry. 279: 43708-15. PMID 15292225 DOI: 10.1074/Jbc.M406568200  0.444
2004 Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences. 1024: 86-101. PMID 15265775 DOI: 10.1196/Annals.1321.007  0.441
2004 Pineda Torra I, Freedman LP, Garabedian MJ. Identification of DRIP205 as a coactivator for the Farnesoid X receptor. The Journal of Biological Chemistry. 279: 36184-91. PMID 15187081 DOI: 10.1074/Jbc.M405126200  0.494
2004 Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. The Journal of Biological Chemistry. 279: 13944-52. PMID 14711828 DOI: 10.1074/Jbc.M306576200  0.426
2003 Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, Yamamoto KR. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 100: 13845-50. PMID 14617768 DOI: 10.1073/Pnas.2336092100  0.74
2003 Wang Z, Garabedian MJ. Modulation of glucocorticoid receptor transcriptional activation, phosphorylation, and growth inhibition by p27Kip1. The Journal of Biological Chemistry. 278: 50897-901. PMID 14534302 DOI: 10.1074/Jbc.M310297200  0.468
2003 Oxelmark E, Knoblauch R, Arnal S, Su LF, Schapira M, Garabedian MJ. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. The Journal of Biological Chemistry. 278: 36547-55. PMID 12835317 DOI: 10.1074/Jbc.M305960200  0.763
2003 Lee M, Yee H, Guller S, Swenson N, Baergen R, Garabedian M. Expression of the glucocorticoid receptor in the human placenta throughout gestation American Journal of Obstetrics and Gynecology. 189: S193. DOI: 10.1016/J.Ajog.2003.10.494  0.377
2003 Lynch D, Lee M, Nathanielsz P, Guller S, Swenson N, Garabedian M. Glucocorticoid receptor expression in fetal non-human primate lung American Journal of Obstetrics and Gynecology. 189: S162. DOI: 10.1016/J.Ajog.2003.10.374  0.322
2002 Su LF, Wang Z, Garabedian MJ. Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement. The Journal of Biological Chemistry. 277: 37037-44. PMID 12138084 DOI: 10.1074/Jbc.M111607200  0.745
2002 Wang Z, Frederick J, Garabedian MJ. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. The Journal of Biological Chemistry. 277: 26573-80. PMID 12000743 DOI: 10.1074/Jbc.M110530200  0.399
2002 Markus SM, Taneja SS, Logan SK, Li W, Ha S, Hittelman AB, Rogatsky I, Garabedian MJ. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Molecular Biology of the Cell. 13: 670-82. PMID 11854421 DOI: 10.1091/Mbc.01-10-0513  0.809
2001 Taneja SS, Susan Ha BS, Garabedian MJ. Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression Journal of Cellular Biochemistry. 84: 188-200. PMID 11746527 DOI: 10.1002/Jcb.1278  0.416
2001 Su LF, Knoblauch R, Garabedian MJ. Rho GTPases as modulators of the estrogen receptor transcriptional response. The Journal of Biological Chemistry. 276: 3231-7. PMID 11060289 DOI: 10.1074/Jbc.M005547200  0.811
2000 Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ, Archer TK. Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells Journal of Biological Chemistry. 275: 17771-17777. PMID 10748103 DOI: 10.1074/Jbc.M908729199  0.395
1999 Hittelman AB, Burakov D, Iñiguez-Lluhí JA, Freedman LP, Garabedian MJ. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. The Embo Journal. 18: 5380-8. PMID 10508170 DOI: 10.1093/Emboj/18.19.5380  0.753
1999 Rogatsky I, Trowbridge JM, Garabedian MJ. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. The Journal of Biological Chemistry. 274: 22296-302. PMID 10428798 DOI: 10.1074/Jbc.274.32.22296  0.434
1999 Rogatsky I, Hittelman AB, Pearce D, Garabedian MJ. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids. Molecular and Cellular Biology. 19: 5036-49. PMID 10373553 DOI: 10.1128/Mcb.19.7.5036  0.766
1999 Knoblauch R, Garabedian MJ. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction Molecular and Cellular Biology. 19: 3748-3759. PMID 10207098 DOI: 10.1128/Mcb.19.5.3748  0.72
1999 Taneja SS, Ha S, Rosenblum N, Garabedian MJ. The Role Of Retinoblastoma Protein (Rb) Degradation In The Androgen Regulation Of Prostate Cancer Growth The Journal of Urology. 130. DOI: 10.1097/00005392-199904010-00523  0.345
1999 Taneja SS, Hittelman A, Tanese N, Ha S, Garabedian M. THE ANDROGEN RECEPTOR COACTIVATOR FUNCTION OF hTAFII 130, A COMPONENT OF THE TFIID COMPLEX OF RNA POLYMERASE The Journal of Urology. 57. DOI: 10.1097/00005392-199904010-00232  0.325
1998 Rogatsky I, Waase CLM, Garabedian MJ. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3): Species- specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation Journal of Biological Chemistry. 273: 14315-14321. PMID 9603939 DOI: 10.1074/Jbc.273.23.14315  0.434
1998 Rogatsky I, Logan SK, Garabedian MJ. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase Proceedings of the National Academy of Sciences of the United States of America. 95: 2050-2055. PMID 9482836 DOI: 10.1073/Pnas.95.5.2050  0.439
1997 Trowbridge JM, Rogatsky I, Garabedian MJ. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proceedings of the National Academy of Sciences of the United States of America. 94: 10132-7. PMID 9294175 DOI: 10.1073/Pnas.94.19.10132  0.469
1997 Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Molecular and Cellular Biology. 17: 3947-54. PMID 9199329 DOI: 10.1128/Mcb.17.7.3947  0.614
1997 Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Molecular and Cellular Biology. 17: 3181-93. PMID 9154817 DOI: 10.1128/Mcb.17.6.3181  0.491
1997 Hong H, Kohli K, Garabedian MJ, Stallcup MR. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors Molecular and Cellular Biology. 17: 2735-2744. PMID 9111344 DOI: 10.1128/Mcb.17.5.2735  0.377
1996 Xu M, Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS. Modular structure of glucocorticoid receptor domains is not equivalent to functional independence. Stability and activity of the steroid binding domain are controlled by sequences in separate domains. The Journal of Biological Chemistry. 271: 21430-8. PMID 8702925 DOI: 10.1074/Jbc.271.35.21430  0.559
1996 Logan SK, Garabedian MJ, Campbell CE, Werb Z. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors Journal of Biological Chemistry. 271: 774-782. PMID 8557686 DOI: 10.1074/Jbc.271.2.774  0.37
1996 Rogatsky I, Trowbridge M, Garabedian MJ. Mechanism of glucocorticoid receptor - induced cell cycle arrest Journal of Investigative Medicine. 44: 240a.  0.388
1996 Maürtamgs I, Rogalsky, Knoblauch R, Garabedian MJ. Regulation of estrogen receptor-dependent transcription by a cyclin-dependent kinase Journal of Investigative Medicine. 44: 271a.  0.354
1993 Garabedian MJ. Genetic Approaches to Mammalian Nuclear Receptor Function in Yeast Methods. 5: 138-146. DOI: 10.1006/meth.1993.1018  0.365
1992 Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS. Role of cysteines 640, 656, and 661 in steroid binding to rat glucocorticoid receptors. The Journal of Biological Chemistry. 267: 11366-73. PMID 1597467  0.581
1992 Garabedian MJ, Yamamoto KR. Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Molecular Biology of the Cell. 3: 1245-57. PMID 1457829 DOI: 10.1091/Mbc.3.11.1245  0.601
1991 Chakraborti PK, Garabedian MJ, Yamamoto KR, Simons SS. Creation of "super" glucocorticoid receptors by point mutations in the steroid binding domain. The Journal of Biological Chemistry. 266: 22075-8. PMID 1939229  0.584
1991 Byravan S, Milhon J, Rabindran SK, Olinger B, Garabedian MJ, Danielsen M, Stallcup MR. Two point mutations in the hormone-binding domain of the mouse glucocorticoid receptor that dramatically reduce its function Molecular Endocrinology. 5: 752-758. PMID 1922094 DOI: 10.1210/Mend-5-6-752  0.43
1991 DeFranco DB, Qi M, Borror KC, Garabedian MJ, Brautigan DL. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors Molecular Endocrinology. 5: 1215-1228. PMID 1663212 DOI: 10.1210/Mend-5-9-1215  0.354
1990 Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature. 348: 166-8. PMID 2234079 DOI: 10.1038/348166A0  0.702
1989 Logan SK, Garabedian MJ, Wensink PC. DNA regions that regulate the ovarian transcriptional specificity of Drosophila yolk protein genes. Genes & Development. 3: 1453-61. PMID 2606354 DOI: 10.1101/Gad.3.9.1453  0.713
1987 Garabedian MJ, Shirras AD, Bownes M, Wensink PC. The nucleotide sequence of the gene coding for Drosophila melanogaster yolk protein 3. Gene. 55: 1-8. PMID 3114046 DOI: 10.1016/0378-1119(87)90242-3  0.652
1986 Garabedian MJ, Shepherd BM, Wensink PC. A tissue-specific transcription enhancer from the Drosophila yolk protein 1 gene. Cell. 45: 859-67. PMID 2423251 DOI: 10.1016/0092-8674(86)90560-X  0.679
1985 Shepherd B, Garabedian MJ, Hung MC, Wensink PC. Developmental control of Drosophila yolk protein 1 gene by cis-acting DNA elements. Cold Spring Harbor Symposia On Quantitative Biology. 50: 521-6. PMID 3938365  0.708
1985 Garabedian MJ, Hung MC, Wensink PC. Independent control elements that determine yolk protein gene expression in alternative Drosophila tissues. Proceedings of the National Academy of Sciences of the United States of America. 82: 1396-400. PMID 3919395 DOI: 10.1073/Pnas.82.5.1396  0.716
Show low-probability matches.